PeproMene Bio's Corporate Minority Round

PeproMene Bio raised a round of funding on March 22, 2018. Investors include Binex.

PeproMene Bio (페프로민 바이오) is a virtual biotech company. It is developing novel immune-oncology therapies such as BAF-R CAR-T therapy based on the novel antibodies.…

Articles about PeproMene Bio's Corporate Minority Round: